Biodesix, Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$88M
R&D
$12M
SG&A
$88M
D&A
$6M
Operating Income
$-28M
EBITDA
$-22M
Interest Expense
$8M
Tax Provision
$0
Net Income
$-35M
Operating Margin
-31.5%
Net Margin
-39.8%
Deferred Tax Assets
$2M
Deferred Tax Liabilities
$194K
DTA Valuation Allowance
$107M
Tax Credit Carryforwards
$570K
NOL Carryforwards
$86M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
4.3%
Operating Lease Cost
$2M
Revenue YoY Variation
24.1%
Income YoY Variation
19.2%